Login / Signup

Adoption of a pregnancy-specific intravenous insulin protocol (Pregnancy-IVI) at a regional centre has equivalent safety and efficacy outcomes as a tertiary hospital.

Christopher W RoweVivian QiaoSoundarya RameshPatrick RoseeAngeline SathiakumarSienna McWhae-BrownEliza GriffithsKatie Wynne
Published in: Diabetic medicine : a journal of the British Diabetic Association (2022)
Keyphrases
  • preterm birth
  • pregnancy outcomes
  • type diabetes
  • randomized controlled trial
  • high dose
  • glycemic control
  • electronic health record
  • low dose
  • skeletal muscle